# Integrative transcriptomic analysis reveals oligodendrocyte lineage switching in multiple sclerosis

**Authors:** Zhong-Ze Yan, Pei-Pei Liu, Hong-Zhen Du, Guo-Liang Chai, Zhao-Qian Teng, Chang-Mei Liu

PMC · DOI: 10.26508/lsa.202403150 · Life Science Alliance · 2025-08-04

## TL;DR

This study uses transcriptomic data and machine learning to uncover interactions between oligodendrocytes and immune cells in multiple sclerosis, revealing potential therapeutic targets.

## Contribution

The study identifies lineage switching in oligodendrocytes and novel molecular interactions in MS using integrative transcriptomic and machine learning approaches.

## Key findings

- Increased Pre-OPCs and newly formed oligodendrocytes were found in normal appearing white matter in MS.
- Reduced SIRPA-CD47 interaction in MS lesions may hinder microglial phagocytosis of oligodendrocytes.
- Enhanced CD74-MIF signaling in lesions may cause microglial retention around oligodendrocytes.

## Abstract

Integrative analysis of single-nucleus RNA sequencing with machine learning and cell communication analysis reveals molecular crosstalk between oligodendrocytes and immune cells in multiple sclerosis, identifying potential therapeutic targets.

Multiple sclerosis (MS) is a chronic disease of the central nervous system. The occurrence of MS is a phased process while its cause is still unclear. Here, by combining white matter single-nucleus transcriptomic datasets from MS and control samples, we found molecular crosstalk between oligodendrocytes (OLs) and immune cells involved in MS pathology. Using a machine learning approach, we identified oligodendrocyte precursor cells (OPCs) and OL subtypes at various developmental stages. We highlighted their unique molecular characteristics and analyzed their distribution throughout development, adulthood, and in different regions impacted by MS. We also found an increased number of Pre-OPCs and newly formed oligodendrocytes (NFOLs) in normal appearing white matter (NAWM), which were scarcely detected in MS lesions. By cell communication analysis and in vitro coculture, we found the interaction between SIRPA on microglia and CD47 on stressed oligodendrocytes was significantly reduced in MS lesions compared with NAWM, potentially preventing microglial phagocytosis of OLs. In contrast, CD74-MIF signaling between microglia and OLs was increased in lesions, which may lead to their retention around OLs.

## Linked entities

- **Proteins:** SIRPA (signal regulatory protein alpha), CD47 (CD47 molecule), CD74 (CD74 molecule), MIF (macrophage migration inhibitory factor)
- **Diseases:** multiple sclerosis (MONDO:0005301)

## Full-text entities

- **Genes:** ASPM (assembly factor for spindle microtubules) [NCBI Gene 259266] {aka ASP, Calmbp1, MCPH5}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, OLIG1 (oligodendrocyte transcription factor 1) [NCBI Gene 116448] {aka BHLHB6, BHLHE21}, SERINC5 (serine incorporator 5) [NCBI Gene 256987] {aka C5orf12, TPO1}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, CSPG4 (chondroitin sulfate proteoglycan 4) [NCBI Gene 1464] {aka CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, SLC17A7 (solute carrier family 17 member 7) [NCBI Gene 57030] {aka BNPI, VGLUT1}, ASIC1 (acid sensing ion channel subunit 1) [NCBI Gene 41] {aka ACCN2, ASIC, BNaC2}, ADGRV1 (adhesion G protein-coupled receptor V1) [NCBI Gene 84059] {aka FEB4, GPR98, MASS1, USH2B, USH2C, VLGR1}, TCF7L2 (transcription factor 7 like 2) [NCBI Gene 6934] {aka TCF-4, TCF4}, NEU4 (neuraminidase 4) [NCBI Gene 129807], AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, BCAN (brevican) [NCBI Gene 63827] {aka BEHAB, CSPG7}, ATP10A (ATPase phospholipid transporting 10A (putative)) [NCBI Gene 57194] {aka ATP10C, ATPVA, ATPVC}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, NES (nestin) [NCBI Gene 10763] {aka Nbla00170}, GALNTL6 (polypeptide N-acetylgalactosaminyltransferase like 6) [NCBI Gene 442117] {aka GALNACT20, GALNT17, GalNAc-T6L}, CNP (2',3'-cyclic nucleotide 3' phosphodiesterase) [NCBI Gene 1267] {aka CN37, CNP1, HLD20}, ZFP36L1 (ZFP36 like 1 zinc finger CCCH-type) [NCBI Gene 677] {aka BRF1, Berg36, ERF-1, ERF1, RNF162B, TIS11B}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, CDH20 (cadherin 20) [NCBI Gene 28316] {aka CDH7L3, Cdh7}, CEMIP2 (cell migration inducing hyaluronidase 2) [NCBI Gene 23670] {aka TMEM2}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, SOX6 (SRY-box transcription factor 6) [NCBI Gene 55553] {aka HSSOX6, SOXD, TOLCAS}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, GPR17 (G protein-coupled receptor 17) [NCBI Gene 2840], ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, MOBP (myelin associated oligodendrocyte basic protein) [NCBI Gene 4336], SIRPA (signal regulatory protein alpha) [NCBI Gene 140885] {aka BIT, CD172A, MFR, MYD-1, MYD1, P84}, KLK6 (kallikrein related peptidase 6) [NCBI Gene 5653] {aka Bssp, Klk7, PRSS18, PRSS9, SP59, hK6}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, TOP2A (DNA topoisomerase II alpha) [NCBI Gene 7153] {aka TOP2, TOP2alpha, TOPIIA, TP2A}, ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) [NCBI Gene 3708] {aka ACV, CLA4, INSP3R1, IP3R, IP3R1, PPP1R94}, APOD (apolipoprotein D) [NCBI Gene 347], CARD16 (caspase recruitment domain family member 16) [NCBI Gene 114769] {aka COP, COP1, LLID-114769, PSEUDO-ICE}, SYT1 (synaptotagmin 1) [NCBI Gene 6857] {aka BAGOS, P65, SVP65, SYT}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, PLP1 (proteolipid protein 1) [NCBI Gene 5354] {aka GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, FAR1 (fatty acyl-CoA reductase 1) [NCBI Gene 84188] {aka CSPSD, MLSTD2, PFCRD, SDR10E1}, CTRL (chymotrypsin like) [NCBI Gene 1506] {aka CTRL1}, MAL (mal, T cell differentiation protein (MAL blood group)) [NCBI Gene 4118] {aka HLD28, MVP17, VIP17}, NKX2-2 (NK2 homeobox 2) [NCBI Gene 4821] {aka NKX2.2, NKX2B}, TMEM144 (transmembrane protein 144) [NCBI Gene 55314] {aka SLC35G7}, ITPR2 (inositol 1,4,5-trisphosphate receptor type 2) [NCBI Gene 3709] {aka ANHD, CFAP48, INSP3R2, IP3R2}, RELN (reelin) [NCBI Gene 5649] {aka ETL7, LIS2, PRO1598, RL}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, PMP22 (peripheral myelin protein 22) [NCBI Gene 5376] {aka CIDP, CMT1A, CMT1E, DSS, GAS-3, GAS3}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, OPALIN (oligodendrocytic myelin paranodal and inner loop protein) [NCBI Gene 93377] {aka HTMP10, TMEM10, TMP10}, PCDH15 (protocadherin related 15) [NCBI Gene 65217] {aka CDHR15, DFNB23, USH1F}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, GAD1 (glutamate decarboxylase 1) [NCBI Gene 2571] {aka CPSQ1, DEE89, GAD, GAD-67, SCP}, MAG (myelin associated glycoprotein) [NCBI Gene 4099] {aka GMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75}, RBFOX1 (RNA binding fox-1 homolog 1) [NCBI Gene 54715] {aka 2BP1, A2BP1, FOX-1, FOX1, HRNBP1}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}
- **Diseases:** axonal injury (MESH:D001480), CI (MESH:D002908), neuroinflammation (MESH:D000090862), neurodegeneration (MESH:D019636), AST (MESH:D001254), OPC (MESH:C564935), autoimmune disease (MESH:D001327), neuronal death (MESH:D009410), CA (MESH:D006521), MS (MESH:D009103), OL (MESH:C564538), neurological disease (MESH:D020271), immune dysregulation (OMIM:614878), disease of the central nervous system (MESH:D002493), INFLAMMATORY (MESH:D007249), defective myelination (MESH:D003711), ImOLs (MESH:D056784)
- **Chemicals:** crystal violet (MESH:D005840), P7405 (-), DAPI (MESH:C007293), PEI (MESH:D011094), PBS (MESH:D007854)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HMC3 — Homo sapiens (Human), Transformed cell line (CVCL_II76), MO3.13 — Homo sapiens (Human), Hybrid cell line (CVCL_D357)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12322325/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12322325/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12322325/full.md

---
Source: https://tomesphere.com/paper/PMC12322325